Literature DB >> 10920305

Adverse behavioral and sexual factors in chronic vulvar disease.

M G Marin1, R King, S Sfameni, G J Dennerstein.   

Abstract

OBJECTIVE: We investigated the prevalence of adverse sexual, personal hygiene, and self-treatment behavior among women with chronic benign vulvar and vaginal disorders. STUDY
DESIGN: This study was carried out by means of a scientific clinical audit producing actuarial data by way of a semistructured questionnaire. Subjects consisted of a sample of 530 cases treated at a specialist clinic for vulvar diseases. In addition to clinical and laboratory investigations, the patients were interviewed by the clinic's psychologist, who used a structured interview schedule developed specifically for the study. Descriptive analysis and analysis of variance were used to investigate data.
RESULTS: Most patients remained sexually active in spite of arousal failure and discomfort and engaged in unlubricated and often painful sexual intercourse. Most women engaged in potentially harmful genital hygiene and self-treatment behavior. Adverse self-treatment practices but not adverse genital hygiene practices were associated with greater symptom duration.
CONCLUSIONS: Adverse practices should be addressed during the management of cases of chronic vulvar disease.

Entities:  

Mesh:

Year:  2000        PMID: 10920305     DOI: 10.1067/mob.2000.105815

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Phenotypic Detection of Genitourinary Candidiasis among Sexually Transmitted Disease Clinic Attendees in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria.

Authors:  Oluranti J Obisesan; Olugbenga A Olowe; Samuel S Taiwo
Journal:  J Environ Public Health       Date:  2015-05-07

2.  Feminine hygiene practices among female patients and nurses in Lebanon.

Authors:  Elie Attieh; Samer Maalouf; Dina Roumieh; Pamela Abdayem; Georges AbiTayeh; Assaad Kesrouani
Journal:  Reprod Health       Date:  2016-05-23       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.